These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25096993)

  • 1. Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction.
    Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
    Int J Oncol; 2014 Oct; 45(4):1769-77. PubMed ID: 25096993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1.
    Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
    Oncol Rep; 2015 May; 33(5):2411-9. PubMed ID: 25738249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma.
    Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L
    Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression.
    Barbone D; Cheung P; Battula S; Busacca S; Gray SG; Longley DB; Bueno R; Sugarbaker DJ; Fennell DA; Broaddus VC
    PLoS One; 2012; 7(12):e52753. PubMed ID: 23300762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cells.
    Leon LG; Gemelli M; Sciarrillo R; Avan A; Funel N; Giovannetti E
    Curr Drug Targets; 2014; 15(14):1331-40. PubMed ID: 25483224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c.
    Ghavami S; Mutawe MM; Hauff K; Stelmack GL; Schaafsma D; Sharma P; McNeill KD; Hynes TS; Kung SK; Unruh H; Klonisch T; Hatch GM; Los M; Halayko AJ
    Biochim Biophys Acta; 2010 Apr; 1803(4):452-67. PubMed ID: 20045437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule-dependent synergistic effect of pemetrexed combined with gemcitabine against malignant pleural mesothelioma and non-small cell lung cancer cell lines.
    Nagai S; Takenaka K; Sonobe M; Wada H; Tanaka F
    Chemotherapy; 2008; 54(3):166-75. PubMed ID: 18560222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells.
    Buqué A; Muhialdin JSh; Muñoz A; Calvo B; Carrera S; Aresti U; Sancho A; Rubio I; López-Vivanco G
    Mol Cancer; 2012 Apr; 11():25. PubMed ID: 22537194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic induction of apoptosis by sulindac and simvastatin in A549 human lung cancer cells via reactive oxygen species-dependent mitochondrial dysfunction.
    Hwang KE; Park C; Kwon SJ; Kim YS; Park DS; Lee MK; Kim BR; Park SH; Yoon KH; Jeong ET; Kim HR
    Int J Oncol; 2013 Jul; 43(1):262-70. PubMed ID: 23661227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
    Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
    Giovannetti E; Lemos C; Tekle C; Smid K; Nannizzi S; Rodriguez JA; Ricciardi S; Danesi R; Giaccone G; Peters GJ
    Mol Pharmacol; 2008 Apr; 73(4):1290-300. PubMed ID: 18187583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim.
    Abayasiriwardana KS; Barbone D; Kim KU; Vivo C; Lee KK; Dansen TB; Hunt AE; Evan GI; Broaddus VC
    Mol Cancer Ther; 2007 Oct; 6(10):2766-76. PubMed ID: 17938269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination effect of photodynamic therapy using NPe6 with pemetrexed for human malignant pleural mesothelioma cells.
    Maehara S; Usuda J; Ishizumi T; Ichinose S; Ohtani K; Inoue T; Imai K; Furumoto H; Kudo Y; Kajiwara N; Ohira T; Ikeda N
    Int J Oncol; 2015 Feb; 46(2):741-9. PubMed ID: 25385189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells.
    Su L; Liu G; Hao X; Zhong N; Zhong D; Liu X; Singhal S
    Eur J Cancer; 2011 Nov; 47(16):2471-8. PubMed ID: 21726997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.
    Yan J; Zhong N; Liu G; Chen K; Liu X; Su L; Singhal S
    Cell Death Dis; 2014 Jul; 5(7):e1316. PubMed ID: 24991768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-oxidant activity of sulforaphane and cisplatin potentiates apoptosis and simultaneously promotes autophagy in malignant mesothelioma cells.
    Lee YJ; Lee SH
    Mol Med Rep; 2017 Aug; 16(2):2133-2141. PubMed ID: 28627624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.
    Nishikawa S; Tanaka A; Matsuda A; Oida K; Jang H; Jung K; Amagai Y; Ahn G; Okamoto N; Ishizaka S; Matsuda H
    Cancer Med; 2014 Apr; 3(2):416-25. PubMed ID: 24510578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
    Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
    J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin.
    Giovannetti E; Zucali PA; Assaraf YG; Leon LG; Smid K; Alecci C; Giancola F; Destro A; Gianoncelli L; Lorenzi E; Roncalli M; Santoro A; Peters GJ
    Br J Cancer; 2011 Nov; 105(10):1542-53. PubMed ID: 21970874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.